Generative AI and computational drug discovery can rapidly create large numbers of candidate molecules. We help prioritize candidates by evaluating potential cytokine release and immune activation risks, supporting safer...
We provide immune safety expertise to identify and characterize immune activation risks associated with novel therapeutics. Our approach helps reduce development risk and supports safer progression into clinical studies.
We support immunogenicity evaluation of biologics and advanced therapeutics by assessing factors that may contribute to unwanted immune responses. Our services help strengthen candidate selection and support risk-based d...
We help developers evaluate and mitigate cytokine release risks during preclinical development. Our expertise supports biologics, bispecific antibodies, cell therapies, gene therapies and immunotherapies, enabling earlie...